Monitoring Free Tissue Transfer Hemodynamics Using NIRS
NCT ID: NCT06661525
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
60 participants
INTERVENTIONAL
2025-04-20
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Kinetics of Reactive Hyperemia Using Noninvasive Digital Thermal Monitoring
NCT00683150
Free Flap Microcirculatory Monitoring Correlates to Free Flap Temperature Assessment
NCT01235299
The Analysis of Skin Temperature by Long Wave Infrared Imaging to Determine Its Effectiveness as a Predictor of Tissue Injury
NCT00664235
Accuracy of TCOM vs NIRS in Predicting Wound Outcomes in Patients Treated With or Without Revascularization
NCT04223089
Skin Perfusion After Abdominal Surgery
NCT03057249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
HYPOTHESIS: The novel NIRS device is capable of monitoring FTT reconstruction continuously for 72 hours after surgery with minimal interference to patient care, minimal discomfort to the patient, and minimal interference with clinical assessment.
JUSTIFICATION FOR THE STUDY: FTT consists of transplanting skin, muscle or bone along with its feeding blood vessels from one body site to reconstruct a defect created by removing cancerous tumours or traumatic injury at a separate site. The key to the survival of the transplanted tissue is the meticulously created microvascular anastomosis between the blood vessels of the transplanted tissue and the blood vessels of the recipient site. Microsurgical techniques have been refined over time to maintain the patency of the anastomosed blood vessels. Nevertheless, the current FTT failure rate is between 1 and 10%.
When FTT failure occurs, it is a devastating experience for the patient and the surgical team. The patient has to be urgently brought to the operating room for an attempted salvage of the microvascular anastomosis. In the event of unsuccessful salvage, the patient has to undergo multiple surgeries that compound the associated morbidity, prolong hospital stay, and increase health care costs. Early detection of vascular compromise is essential for increasing the odds of successful salvage. Thus, the methods used to monitor the FTT vascular status are critical and have received much attention in the literature. Clinical examination remains the gold standard and the most popular method of monitoring FTT viability. The two downsides of clinical examinations are the requirement for personnel trained and experienced in FTT monitoring and the inability to provide reliable continuous monitoring. Therefore recognition of FTT compromise is often delayed significantly compromising successful surgical salvage attempts.
Recently, NIRS has been recognized as the technology with the most potential to address the problems seen with FTT clinical monitoring. NIRS is a non-invasive technique that passes near-infrared light (600-1000 nm) through the tissues at a depth of 10 to 20 mm. Calculating the amount of absorbed light allows real-time measurements of oxygenated, deoxygenated, and total hemoglobin concentrations. Therefore, an abnormality of tissue perfusion and oxygenation can then be detected instantaneously and confirmed clinically. Reducing the time from detection of vascular compromise to the attempted FTT rescue in the operating room decreases the ischemia time and increases the FTT salvage rate.
A recent meta-analysis concluded that NIRS is "a reliable monitoring technique that is non-invasive, objective, and easy to use". However, there are currently no NIRS systems available that can monitor FTT used in head and neck surgery. This is largely due to the difficulty in creating NIRS sensors that are small enough to be used in the head and neck region. Developing and evaluating a novel, customized NIRS system with a miniaturized sensor suitable for a variety of FTT options is needed, presenting an attractive clinical opportunity.
The proposed study's principal investigator (D.W.A.) is the pioneer of head and neck FTT in British Columbia, with FTT experience spanning over 35 years. He will use his expertise to consult with Dr. Shadgan, a clinical biophotonics research scientist, to provide clinical and technical specifications required for the construction of the NIRS prototype. Currently, they successfully built and tested the miniaturized NIRS sensor on 3 patients, and they were able to obtain promising results. To establish our method and refine the design of the sensor to be compatible with a wide variety of FTT surgeries, The investigators plan to conduct this pilot study.
OBJECTIVES
1. Develop a novel NIRS system with miniaturized sensors suitable for various FTT reconstruction options.
2. Conduct a pilot study on up to 60 patients to determine perfusion thresholds indicative of vascular compromise for a variety of FTT reconstructive options, and to improve the design and application of sensors to the variety of FTT.
RESEARCH DESIGN
The NIRS prototype will be tested intra- and post-operatively on a single patient undergoing FTT reconstruction. Intra-operative NIRS measurements simulating FTT compromise will be collected during a single FTT operation.
Post-operatively the NIRS probe will be placed and fixed over the FTT for 72 hours and its measurements will be recorded. In addition, experienced nurses not involved in the proposed study will monitor the FTT vascular status with the conventional clinical methods currently employed at VGH and Surrey Memorial Hospital. The clinical assessment will be documented in the standardized table and correlated to the NIRS recordings. Finally, at the end of the 72-hours, both the patient and the clinicians will complete questionnaires to evaluate their experience with the NIRS system.
STATISTICAL ANALYSIS
The collected intra-operative and post-operative NIRS measurements will be used to establish a threshold for low perfusion alarm on the NIRS monitor for different types of tissues.
The data that will be collected through patients' and doctors' questionnaires will go through descriptive statistical analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
Data collection from Participants and evaluate their feedback by filling a questioner
Free Flap NIRS
Monitoring of tissue oxygenation after Free Tissue Transfer (FTT) surgeries.
Care providers
Care providers will provide their feedback via questioner
Free Flap NIRS
Monitoring of tissue oxygenation after Free Tissue Transfer (FTT) surgeries.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Free Flap NIRS
Monitoring of tissue oxygenation after Free Tissue Transfer (FTT) surgeries.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of 18 years old or older
Exclusion Criteria
* Metastatic disease
* Pregnant or nursing
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Surrey Memorial Hospital (SMH)
UNKNOWN
Vancouver General Hospital
OTHER
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donald W. Anderson
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Surrey Memorial Hospital
Surrey, British Columbia, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H22-03706
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.